Moleculaire reclassificatie van chronisch inflammatoire aandoeningen voor personalized medicine. Feit of fictie?

Publication date

2017

Authors

Leijten, E F A
Radstake, Timothy R D JISNI 0000000382903168

Editors

Advisors

Supervisors

DOI

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

In this article, some aspects of toothpastes and contact Psoriatic arthritis (PsA) is currently under diagnosed and often resistant to treatment with traditional antirheumatic drugs, leading to increased morbidity and mortality. The UMC Utrecht has a specialized psoriasis clinic run by dermatologists en rheumatologists in which all patients are screened for psoriatic arthritis. This joint effort allows for performing meaningful, translation research. Indeed, the pathogenesis of PsA is not fully understood but thought to arise from the combination of genetic, epigenetic, and environmental factors. The socalled "systems medicine approach" uses high throughput technologies to help unravel the complex interactions between all these factors in order to better understand the specific pathways leading to this disease. The aim is to identify new diagnostic and prognostic biomarkers and novel therapeutic targets.

Keywords

Psoriasis, Psoriatic arthritis (artritis psoriatica), Systems medicine, Taverne, Critical Care and Intensive Care Medicine, Infectious Diseases

Citation

Leijten, E F A & Radstake, T R D J 2017, 'Moleculaire reclassificatie van chronisch inflammatoire aandoeningen voor personalized medicine. Feit of fictie?', Nederlands Tijdschrift voor Dermatologie & Venereologie, vol. 27, no. 4, pp. 153-155.